Published in Medical Device Business Week, May 23rd, 2007
Total product revenues for the first quarter were $6.7 million versus $4.8 million in the comparable 2006 period, a 41% year over year increase. The revenue increases were mainly reflective of Levulan(R) Kerastick(R) unit volume sales growth; as well as a full quarter of non-PDT revenues associated with products acquired in the merger with Sirius Laboratories,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.